MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress » Neuropharmacology

Meeting: 2023 International Congress

Characterisation of the pharmacokinetic profile of L-DOPA in the common marmoset

D. Bédard, F. Gaudette, F. Beaudry, P. Huot (Montreal, Canada)

Demographic, clinical and genetic factors affecting amantadine response among patients with Parkinson disease

J. Yu, L. Saadatpour, H. Kaur, I. Mata, H. Fernandez (Cleveland, USA)

Effect of ADX-88178, a highly-selective mGlu4 PAM, on parkinsonism, dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset

I. Frouni, C. Kwan, D. Bédard, W. Kang, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

Effect of the 5-HT2A/2C inverse agonist nelotanserin on dyskinesia in the MPTP-lesioned marmoset

C. Kwan, I. Frouni, D. Bédard, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

Increased alpha power in basal ganglia and thalamus following levodopa administration in a dystonic young adult

J. Nataraj, J. Maclean, SA. Seyyed Mousavi, J. Olaya, M. Liker, T. Sanger (Irvine, USA)

Motor function in Parkinson´s disease during 16h treatment with intravenously (DIZ101), subcutaneously (DIZ102), or intestinally (LCIG) infused levodopa

F. Bergquist, M. Ehrnebo, D. Nyholm, A. Johansson, F. Lundin, P. Odin, P. Svenningsson, N. Dizdar, E. Eriksson (Gothenburg, Sweden)

Neuroprotective properties of arylpiperazine-sulphonamides in an in vitro model of Parkinson’s disease

A. Kingslake, V. Soskic, M. Iravani (Hatfield, United Kingdom)

Polyaromatic hydrocarbons in Ambient Particulate Matter (PM 2.5) mediate neurodegeneration through the olfactory-brain axis in C57BL/6 mice

SR. Panda, VGM. Naidu (Guwahati, India)

Quantitative investigation of the pathway between dopamine receptors and Ca2+ channels in layer II stellate cells towards Parkinson’s disease

C. Mahapatra, A. Pradhan (MUMBAI, India)

Quetiapine for the treatment of psychosis in dementia with Lewy bodies: a systematic review.

M. Giusti, PL. Silva, G. Bolner, C. Menegon, MF. Felippe, G. Herwig, A. Rossato, EG. Almeida, M. Rosa, CR. Rieder (Porto Alegre, Brazil)

The neuroprotective properties of NLX-112 in MPTP treated mice are mediated by reactive gliosis and astrocytic GDNF

W. Powell, A. Newman-Tancredi, L. Annett, R. Depoortere, M. Iravani (Hatfield, United Kingdom)

« View all sessions from the 2023 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Advanced Search
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Welcome to the MDS Abstracts Site
  • Advanced Search
  • #23972 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Insulin dependent diabetes and hand tremor
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley